Intelligence / Healthtech / FDA 510(k) Clearances / SimBioSys, Inc.
Approvalsdevice cleared25 Sept 2026
SimBioSys, Inc.
25 Sept 2026: Device cleared · TumorSight Risk. Recorded in the openFDA device 510(k) data.
- Decided
- 25 Sept 2026
- Device
- TumorSight Risk
- Specialty
- Pathology
- Country
- United States
- Location
- Chicago, IL
- Clearance type
- Traditional
- 510(k) number
- K260023
- Submitted
- 2026-01-05
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at SimBioSys, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Pathology
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.